Like most things in 2021, this year’s Joint Commission compounding pharmacy surveys will take a different tack, based in part on the practice pressures of COVID-19. The main development is a continued delay in enforcing recent updates to USP’s Chapters on compounding and hazardous drug handling, along with a pandemic-related interim guidance issued for compounding pharmacies.
For pharmacies that scrambled to obtain funding to build cleanrooms and update existing